- Home
- Automated
- List of product information
- NAUSICALM TABLET 50MG [SIN15193P]
NAUSICALM TABLET 50MG [SIN15193P]
Active ingredients: NAUSICALM TABLET 50MG
Last updated 26 October 2025
Product Info
NAUSICALM TABLET 50MG
[SIN15193P]
Product information
Active Ingredient and Strength | CYCLIZINE HYDROCHLORIDE - 50 MG |
Dosage Form | TABLET |
Manufacturer and Country | SIGMA LABORATORIES LTD. - INDIA |
Registration Number | SIN15193P |
Licence Holder | APEX PHARMA MARKETING PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | R06AE03 |
Indications
Nausicalm is indicated for the prevention and treatment of nausea and vomiting associated with motion sickness and radiotherapy.
Dosage and Administration
For the Treatment of nausea induced by radiotherapy:
Adults and children over 12 Years: One tablet every 6 to 8 hours, as required with a little water (up to a maximum of 3 tablets in 24 hours)
Use in the Elderly: There have been no specific studies of cyclizine in the elderly. Experience has indicated that normal adult dosage is appropriate.
For the Prevention of Travel Sickness:
Adults and children over 12 Years: One tablet every 6 to 8 hours (up to a maximum of 3 tablets in 24 hours), as required with a little water, first taken 1–2 hours before departure.
The score line only serves to facilitate breaking for ease of swallowing and does not divide the tablet into equal half-doses.
This product should not be used for more than 48 hours at a time
Contraindications
Nausicalm should not be given to individuals with known hypersensitivity to cyclizine or in individuals with severe heart failure.